Breaking News, Collaborations & Alliances

BMS Forms Immuno-Oncology Network

II-ON covers 10 academic institutions

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Bristol-Myers Squibb has formed the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia intended to further the scientific understanding of immuno-oncology. Immuno-oncology focuses on the potential of harnessing the body’s immune system to fight cancer. In addition to BMS, the II-ON is currently comprised of ten leading cancer-research institutions, including: Clinica Universidad Navarra, Pamplona, Spain Dana-Farber Cancer Institute, Bosto...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters